Concepts (249)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 2 | 3 | 2019 | 148 | 1.090 |
Why?
|
| Magnetic Resonance Imaging | 10 | 2022 | 880 | 1.010 |
Why?
|
| Cerebral Hemorrhage | 5 | 2022 | 104 | 0.790 |
Why?
|
| Brain Mapping | 6 | 2021 | 123 | 0.780 |
Why?
|
| Blood Glucose | 2 | 2020 | 99 | 0.760 |
Why?
|
| Biomarkers | 3 | 2020 | 487 | 0.680 |
Why?
|
| Neuregulins | 1 | 2019 | 1 | 0.640 |
Why?
|
| Headache | 1 | 2019 | 38 | 0.620 |
Why?
|
| Mean Platelet Volume | 1 | 2018 | 1 | 0.590 |
Why?
|
| Diabetic Nephropathies | 1 | 2018 | 17 | 0.590 |
Why?
|
| Lymphocytes | 1 | 2018 | 57 | 0.580 |
Why?
|
| Circle of Willis | 1 | 2017 | 5 | 0.530 |
Why?
|
| Sclerosis | 1 | 2017 | 56 | 0.520 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2017 | 29 | 0.520 |
Why?
|
| Temporal Lobe | 1 | 2017 | 63 | 0.510 |
Why?
|
| Humans | 43 | 2022 | 23331 | 0.500 |
Why?
|
| Middle Aged | 22 | 2021 | 8055 | 0.500 |
Why?
|
| Adult | 22 | 2021 | 7070 | 0.500 |
Why?
|
| Female | 27 | 2021 | 13124 | 0.490 |
Why?
|
| Thalamus | 4 | 2021 | 15 | 0.480 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 5 | 2022 | 88 | 0.480 |
Why?
|
| Image Enhancement | 2 | 2020 | 43 | 0.460 |
Why?
|
| Male | 27 | 2021 | 12629 | 0.460 |
Why?
|
| Brain | 6 | 2021 | 1200 | 0.460 |
Why?
|
| Diffusion Tensor Imaging | 3 | 2021 | 48 | 0.430 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2010 | 59 | 0.370 |
Why?
|
| Diagnostic Imaging | 2 | 2020 | 72 | 0.350 |
Why?
|
| Aged | 14 | 2021 | 7552 | 0.350 |
Why?
|
| Brain Ischemia | 2 | 2021 | 61 | 0.320 |
Why?
|
| Young Adult | 6 | 2021 | 1674 | 0.310 |
Why?
|
| Evoked Potentials, Motor | 1 | 2009 | 10 | 0.300 |
Why?
|
| Motor Cortex | 1 | 2009 | 16 | 0.300 |
Why?
|
| Neurodegenerative Diseases | 1 | 2010 | 93 | 0.300 |
Why?
|
| Brain Diseases | 1 | 2009 | 55 | 0.300 |
Why?
|
| Graft Rejection | 2 | 2018 | 61 | 0.270 |
Why?
|
| Contrast Media | 3 | 2020 | 60 | 0.270 |
Why?
|
| Cross-Sectional Studies | 3 | 2019 | 774 | 0.260 |
Why?
|
| Liver Transplantation | 2 | 2018 | 91 | 0.250 |
Why?
|
| Case-Control Studies | 4 | 2021 | 482 | 0.250 |
Why?
|
| Risk Factors | 7 | 2021 | 1998 | 0.240 |
Why?
|
| Auditory Cortex | 1 | 2005 | 3 | 0.240 |
Why?
|
| Language | 1 | 2005 | 58 | 0.230 |
Why?
|
| Sex Characteristics | 1 | 2005 | 86 | 0.230 |
Why?
|
| Postoperative Complications | 3 | 2020 | 836 | 0.220 |
Why?
|
| Brain Neoplasms | 2 | 2021 | 90 | 0.200 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2008 | 27 | 0.200 |
Why?
|
| Retrospective Studies | 9 | 2021 | 3040 | 0.190 |
Why?
|
| Turkey | 2 | 2018 | 6 | 0.180 |
Why?
|
| Radiology | 1 | 2021 | 16 | 0.180 |
Why?
|
| Encephalocele | 1 | 2021 | 21 | 0.180 |
Why?
|
| Patient Care Planning | 1 | 2001 | 35 | 0.180 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2001 | 45 | 0.170 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 84 | 0.170 |
Why?
|
| Antiviral Agents | 1 | 2021 | 66 | 0.170 |
Why?
|
| Nerve Net | 1 | 2021 | 34 | 0.170 |
Why?
|
| Glioma | 1 | 2021 | 23 | 0.170 |
Why?
|
| Adenolymphoma | 1 | 2020 | 4 | 0.170 |
Why?
|
| Adenoma, Pleomorphic | 1 | 2020 | 6 | 0.170 |
Why?
|
| Thyroid Neoplasms | 2 | 2017 | 44 | 0.170 |
Why?
|
| Kidney Neoplasms | 1 | 2001 | 75 | 0.170 |
Why?
|
| Hyperglycemia | 1 | 2020 | 27 | 0.170 |
Why?
|
| Facial Nerve | 1 | 2020 | 10 | 0.170 |
Why?
|
| Gray Matter | 1 | 2021 | 39 | 0.170 |
Why?
|
| Dissection | 1 | 2020 | 22 | 0.170 |
Why?
|
| Parotid Gland | 1 | 2020 | 17 | 0.170 |
Why?
|
| Parotid Neoplasms | 1 | 2020 | 14 | 0.170 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2020 | 24 | 0.170 |
Why?
|
| Kidney | 1 | 2001 | 142 | 0.170 |
Why?
|
| Hospital Mortality | 1 | 2021 | 133 | 0.170 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2020 | 8 | 0.160 |
Why?
|
| Artifacts | 1 | 2020 | 29 | 0.160 |
Why?
|
| White Matter | 2 | 2019 | 109 | 0.160 |
Why?
|
| Cerebral Cortex | 1 | 2021 | 127 | 0.160 |
Why?
|
| Fasting | 1 | 2019 | 19 | 0.160 |
Why?
|
| Hernia | 1 | 2019 | 7 | 0.160 |
Why?
|
| Acute Disease | 2 | 2019 | 168 | 0.160 |
Why?
|
| Neuroma, Acoustic | 1 | 2019 | 3 | 0.160 |
Why?
|
| Brain Edema | 1 | 2019 | 18 | 0.160 |
Why?
|
| Movement | 1 | 2020 | 104 | 0.160 |
Why?
|
| Liver Neoplasms | 2 | 2018 | 103 | 0.160 |
Why?
|
| Atrial Fibrillation | 1 | 2021 | 98 | 0.160 |
Why?
|
| Emergencies | 1 | 2019 | 29 | 0.160 |
Why?
|
| Recovery of Function | 1 | 2020 | 246 | 0.150 |
Why?
|
| Sarcoidosis | 1 | 2019 | 12 | 0.150 |
Why?
|
| Central Nervous System Diseases | 1 | 2019 | 14 | 0.150 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2019 | 7 | 0.150 |
Why?
|
| Diabetes, Gestational | 1 | 2019 | 8 | 0.150 |
Why?
|
| Adolescent | 4 | 2020 | 1916 | 0.150 |
Why?
|
| Spinal Cord Diseases | 1 | 2019 | 47 | 0.150 |
Why?
|
| Stomach | 1 | 2018 | 14 | 0.150 |
Why?
|
| Computed Tomography Angiography | 1 | 2018 | 27 | 0.150 |
Why?
|
| Lymphocyte Count | 1 | 2018 | 16 | 0.150 |
Why?
|
| Cerebral Angiography | 1 | 2018 | 29 | 0.150 |
Why?
|
| Obesity, Abdominal | 1 | 2018 | 19 | 0.150 |
Why?
|
| Adiposity | 1 | 2019 | 42 | 0.150 |
Why?
|
| Weight Gain | 1 | 2019 | 59 | 0.150 |
Why?
|
| Brain Abscess | 1 | 2018 | 4 | 0.140 |
Why?
|
| Intra-Abdominal Fat | 1 | 2018 | 40 | 0.140 |
Why?
|
| Cystic Fibrosis | 1 | 2018 | 10 | 0.140 |
Why?
|
| Intracranial Pressure | 1 | 2018 | 11 | 0.140 |
Why?
|
| Cerebrovascular Disorders | 1 | 2019 | 99 | 0.140 |
Why?
|
| Pediatric Obesity | 1 | 2019 | 43 | 0.140 |
Why?
|
| Child Development | 1 | 2019 | 68 | 0.140 |
Why?
|
| Kidney Diseases | 1 | 2018 | 69 | 0.140 |
Why?
|
| Spinal Diseases | 1 | 2019 | 108 | 0.140 |
Why?
|
| Nerve Fibers | 1 | 2018 | 11 | 0.140 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2018 | 25 | 0.140 |
Why?
|
| Pregnancy | 1 | 2019 | 322 | 0.140 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2018 | 593 | 0.140 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2018 | 139 | 0.140 |
Why?
|
| Erythrocyte Indices | 1 | 2017 | 4 | 0.140 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2018 | 203 | 0.140 |
Why?
|
| Thyroid Nodule | 1 | 2017 | 9 | 0.140 |
Why?
|
| Biliary Tract | 1 | 2017 | 3 | 0.140 |
Why?
|
| Cholestasis, Extrahepatic | 1 | 2017 | 3 | 0.140 |
Why?
|
| Cysts | 1 | 2017 | 14 | 0.130 |
Why?
|
| Leukoencephalopathies | 1 | 2017 | 11 | 0.130 |
Why?
|
| Anastomosis, Surgical | 1 | 2017 | 27 | 0.130 |
Why?
|
| Constriction, Pathologic | 1 | 2017 | 27 | 0.130 |
Why?
|
| Calcinosis | 1 | 2017 | 43 | 0.130 |
Why?
|
| Sensitivity and Specificity | 4 | 2022 | 452 | 0.130 |
Why?
|
| Epithalamus | 1 | 2016 | 2 | 0.130 |
Why?
|
| Afferent Pathways | 1 | 2016 | 4 | 0.130 |
Why?
|
| Functional Laterality | 1 | 2017 | 56 | 0.130 |
Why?
|
| Prospective Studies | 5 | 2021 | 1523 | 0.130 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 254 | 0.130 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 198 | 0.120 |
Why?
|
| Cervical Vertebrae | 1 | 2019 | 274 | 0.120 |
Why?
|
| Child | 3 | 2021 | 1171 | 0.120 |
Why?
|
| Stroke | 1 | 2018 | 240 | 0.120 |
Why?
|
| Radiopharmaceuticals | 2 | 2010 | 48 | 0.120 |
Why?
|
| Aged, 80 and over | 5 | 2021 | 3783 | 0.110 |
Why?
|
| Dominance, Cerebral | 2 | 2005 | 15 | 0.110 |
Why?
|
| Spinal Fusion | 1 | 2020 | 430 | 0.100 |
Why?
|
| Parkinson Disease | 2 | 2018 | 586 | 0.100 |
Why?
|
| Corpus Callosum | 2 | 2019 | 11 | 0.100 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2006 | 158 | 0.100 |
Why?
|
| Aging | 1 | 2019 | 1098 | 0.090 |
Why?
|
| Prognosis | 3 | 2020 | 740 | 0.090 |
Why?
|
| Follow-Up Studies | 4 | 2020 | 1441 | 0.090 |
Why?
|
| Time Factors | 3 | 2020 | 1289 | 0.090 |
Why?
|
| Dementia, Vascular | 1 | 2010 | 35 | 0.080 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 442 | 0.080 |
Why?
|
| Diagnosis, Differential | 3 | 2019 | 322 | 0.080 |
Why?
|
| Neuroradiography | 1 | 2009 | 1 | 0.080 |
Why?
|
| Pediatrics | 1 | 2009 | 38 | 0.070 |
Why?
|
| Subclavian Artery | 1 | 2008 | 3 | 0.070 |
Why?
|
| Vertebral Artery | 1 | 2008 | 4 | 0.070 |
Why?
|
| Reference Values | 1 | 2009 | 167 | 0.070 |
Why?
|
| Echo-Planar Imaging | 2 | 2005 | 4 | 0.070 |
Why?
|
| Hospitalization | 2 | 2021 | 290 | 0.070 |
Why?
|
| Thallium Radioisotopes | 3 | 1999 | 5 | 0.070 |
Why?
|
| Pilot Projects | 1 | 2009 | 380 | 0.070 |
Why?
|
| Risk Assessment | 2 | 2021 | 565 | 0.070 |
Why?
|
| Technetium Tc 99m Sestamibi | 3 | 1999 | 11 | 0.070 |
Why?
|
| Graft Survival | 2 | 2018 | 84 | 0.070 |
Why?
|
| Organotechnetium Compounds | 3 | 1999 | 7 | 0.070 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 594 | 0.070 |
Why?
|
| Body Mass Index | 2 | 2019 | 384 | 0.060 |
Why?
|
| Longitudinal Studies | 2 | 2020 | 1050 | 0.060 |
Why?
|
| Survival Rate | 2 | 2018 | 323 | 0.060 |
Why?
|
| Neural Pathways | 1 | 2006 | 55 | 0.060 |
Why?
|
| Treatment Outcome | 2 | 2021 | 2988 | 0.050 |
Why?
|
| Paranasal Sinus Diseases | 1 | 2003 | 13 | 0.050 |
Why?
|
| Frontal Sinus | 1 | 2003 | 13 | 0.050 |
Why?
|
| Aphasia, Broca | 1 | 2003 | 2 | 0.050 |
Why?
|
| Regional Blood Flow | 1 | 2003 | 8 | 0.050 |
Why?
|
| Nerve Regeneration | 1 | 2003 | 13 | 0.050 |
Why?
|
| Astrocytoma | 1 | 2003 | 18 | 0.050 |
Why?
|
| Frontal Lobe | 1 | 2003 | 53 | 0.050 |
Why?
|
| Child, Preschool | 2 | 2019 | 578 | 0.050 |
Why?
|
| Neuronal Plasticity | 1 | 2003 | 39 | 0.050 |
Why?
|
| Blindness | 1 | 2022 | 9 | 0.050 |
Why?
|
| Prevalence | 2 | 2018 | 384 | 0.050 |
Why?
|
| Iliac Artery | 1 | 2001 | 5 | 0.050 |
Why?
|
| Renal Artery | 1 | 2001 | 6 | 0.050 |
Why?
|
| Cerebrospinal Fluid Otorrhea | 1 | 2021 | 3 | 0.040 |
Why?
|
| Petrous Bone | 1 | 2021 | 4 | 0.040 |
Why?
|
| Pelvis | 1 | 2001 | 23 | 0.040 |
Why?
|
| Multimodal Imaging | 1 | 2021 | 27 | 0.040 |
Why?
|
| Equipment Failure | 1 | 2020 | 35 | 0.040 |
Why?
|
| Globus Pallidus | 1 | 2019 | 10 | 0.040 |
Why?
|
| Caudate Nucleus | 1 | 2019 | 11 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2019 | 30 | 0.040 |
Why?
|
| Sex Factors | 1 | 2021 | 391 | 0.040 |
Why?
|
| Spine | 1 | 2020 | 97 | 0.040 |
Why?
|
| Radionuclide Imaging | 5 | 1999 | 41 | 0.040 |
Why?
|
| Carcinoma, Medullary | 1 | 1999 | 6 | 0.040 |
Why?
|
| Tennessee | 1 | 2018 | 6 | 0.040 |
Why?
|
| Ileum | 1 | 2018 | 14 | 0.040 |
Why?
|
| Gastrointestinal Transit | 1 | 1998 | 12 | 0.040 |
Why?
|
| Bacterial Translocation | 1 | 1998 | 19 | 0.040 |
Why?
|
| Intestinal Diseases | 1 | 2018 | 7 | 0.040 |
Why?
|
| Renal Replacement Therapy | 1 | 2018 | 18 | 0.040 |
Why?
|
| Neurosurgical Procedures | 1 | 2020 | 140 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2018 | 60 | 0.040 |
Why?
|
| ROC Curve | 1 | 2018 | 125 | 0.040 |
Why?
|
| Pseudomonas Infections | 1 | 2018 | 32 | 0.040 |
Why?
|
| Intestines | 1 | 1998 | 76 | 0.040 |
Why?
|
| Metabolic Syndrome | 1 | 2018 | 55 | 0.040 |
Why?
|
| Diabetes Mellitus | 1 | 2018 | 109 | 0.030 |
Why?
|
| Thyroidectomy | 1 | 2017 | 18 | 0.030 |
Why?
|
| Smoking | 1 | 2018 | 168 | 0.030 |
Why?
|
| Preoperative Care | 1 | 2018 | 112 | 0.030 |
Why?
|
| Infant | 1 | 2019 | 486 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2019 | 540 | 0.030 |
Why?
|
| Mothers | 1 | 2019 | 160 | 0.030 |
Why?
|
| Habenula | 1 | 2016 | 2 | 0.030 |
Why?
|
| Length of Stay | 1 | 2018 | 305 | 0.030 |
Why?
|
| Deep Brain Stimulation | 1 | 2016 | 40 | 0.030 |
Why?
|
| Succimer | 1 | 1995 | 1 | 0.030 |
Why?
|
| Technetium Tc 99m Medronate | 1 | 1995 | 2 | 0.030 |
Why?
|
| Hemangioma | 1 | 1995 | 8 | 0.030 |
Why?
|
| Thymoma | 1 | 1995 | 7 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 291 | 0.030 |
Why?
|
| Thymus Neoplasms | 1 | 1995 | 12 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 363 | 0.030 |
Why?
|
| Thymus Gland | 1 | 1995 | 11 | 0.030 |
Why?
|
| Parathyroid Glands | 1 | 1995 | 8 | 0.030 |
Why?
|
| Sugar Acids | 1 | 1994 | 1 | 0.030 |
Why?
|
| Behcet Syndrome | 1 | 1994 | 3 | 0.030 |
Why?
|
| Uveitis | 1 | 1994 | 10 | 0.030 |
Why?
|
| United States | 1 | 2019 | 1829 | 0.030 |
Why?
|
| Arteritis | 1 | 2008 | 1 | 0.020 |
Why?
|
| Aneurysm | 1 | 2008 | 10 | 0.020 |
Why?
|
| Technetium Tc 99m Dimercaptosuccinic Acid | 2 | 1999 | 2 | 0.020 |
Why?
|
| Medical Illustration | 1 | 2006 | 11 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2003 | 52 | 0.010 |
Why?
|
| Research Design | 1 | 2003 | 157 | 0.010 |
Why?
|
| Neurons | 1 | 2003 | 272 | 0.010 |
Why?
|
| Organophosphorus Compounds | 1 | 1999 | 5 | 0.010 |
Why?
|
| Calcitonin | 1 | 1999 | 14 | 0.010 |
Why?
|
| Parenteral Nutrition, Total | 1 | 1998 | 2 | 0.010 |
Why?
|
| Parasympathomimetics | 1 | 1998 | 4 | 0.010 |
Why?
|
| Peristalsis | 1 | 1998 | 11 | 0.010 |
Why?
|
| Neostigmine | 1 | 1998 | 4 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1998 | 54 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 1999 | 87 | 0.010 |
Why?
|
| Soft Tissue Neoplasms | 1 | 1999 | 53 | 0.010 |
Why?
|
| Morphine | 1 | 1998 | 70 | 0.010 |
Why?
|
| Bone Neoplasms | 1 | 1999 | 118 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 1999 | 200 | 0.010 |
Why?
|
| Rats | 1 | 1998 | 625 | 0.010 |
Why?
|
| Parathyroid Neoplasms | 1 | 1995 | 5 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 1995 | 30 | 0.010 |
Why?
|
| Adenoma | 1 | 1995 | 61 | 0.010 |
Why?
|
| Ultrasonography | 1 | 1995 | 204 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 1999 | 542 | 0.010 |
Why?
|
| Animals | 1 | 1998 | 3287 | 0.010 |
Why?
|